1063 difference in the enzyme activity between the untreated and stimulated cells in all treatment groups. However, a dose dependent decrease was observed only in case of CD14 cells. Both unsorted monocytes and monocyte sub-populations showed a significant decrease in the concentration of cortisol measured when co-incubated with carbenoxolone, indicative of the direct involvement of 11β-HSD1 enzyme in the conversion of cortisone to cortisol.
AB0047 TYPE I INTERFERON IS HIGHLY EXPRESSED IN RA SYNOVIAL FLUID AND JOINT CARTILAGE CORRELATED WITH SERUM RHEUMATOID FACTOR; A PRELIMINARY EXPERIMENTAL STUDY
Background: It was reported that type I interferon (IFN) is involved in the pathogenesis of rheumatoid arthritis (RA) [1] [2] [3] , while the relevance of the IFN signature to RA disease activity and progression remains unclear. There were few reports about the expression of IFN in synovial fluid and joint cartilage. Objectives: The aim of this study is to investigate the role of IFN in the pathogenesis of RA by means of the analysis of joint tissues of RA patients comparing with those of osteoarthritis (OA) patients. Methods: Synovial fluid, synovia and cartilage were collected from RA and OA patients (n=10 for each) during total knee arthroplasty in our hospital and blood samples were collected just before surgery. As preoperative therapy for RA, Methotrexate (MTX) was administered to 9 patients (dose ranged (4-12mg), DMARDS without MTX to 2, biological DMARDS to 2, Prednisolone (PSL) to 6 (dose 1-5mg). Quantities of IFN alpha or beta of blood and joint fluid were measured with ELISA (PBL Assay Science, USA), and expression of IFN alpha, beta and TNF alpha of synovia and joint cartilage were measured with real time PCR. In RA patients. Serum biomarkers such as C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), Rheumatoid Factor (RF), hemoglobin and platelet were measured and investigated correlation with the quantities of IFN of blood or joint tissues. Medication for RA were investigated as well. Results: In blood and synovial fluid of RA patients, IFN alpha and beta were highly detected, while they were not detected in those of OA patients. The expression of IFN alpha and beta of RA cartilage were much higher than those of OA whereas they were not expressed in synovium of both RA and OA. Expression of IFN was not correlated with that of TNF alpha in RA patients. Statistical analysis revealed that RF was related with blood and joint IFN and other markers were not. Medications for RA were not correlated with IFN expression. Conclusions: IFN was highly expressed in RA synovial fluid, joint cartilage and blood, not in OA. IFN immunotherapy has been reported to induce RA [4] [5] , therefore abundant IFN might induce RA and inhibit cure of RA. Our results showed that RF was related with blood and joint IFN. It can be speculated that RF might be an index of IFN regulation in RA patient, however, more samples must be investigated to prove this speculation. Background: Systemic inflammation has been postulated to be an independent cardiovascular risk factor, particularly in patients with autoimmune rheumatic disorders (ARD), such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), and is associated with accelerated atherosclerosis. There is some evidence to suggest that antiphospholipid antibodies (aPL) may also play a role in the development of atherosclerosis. However, it is few data about the relationship between these autoantibodies and inflammatory mediators in the development of atherosclerosis. Objectives: To clarify the involvement of inflammatory mediators and aPL in the atherosclerotic process in patients with ARD. Methods: The study included 87 female patients with ARD (RA (n=47), mean age 45,0 (33,0; 51,0) years old, disease duration 9,0 (3,0; 14,0) years, disease activity (DAS28=5,37 (4,69; 5,86) points); SLE (n=40), mean age 33,5 (27,5; 44,5) years old, disease duration 8,0 (5,0; 14,5) years, disease activity SLEDAI-2K 7,0 (4,0; 11,5) points). Sixty healthy women (mean age 40,5 (36,0; 47,0) years old) formed the control group. The levels of high sensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6), tumor necrosis factor -α (TNF-α), LA, IgG/IgM antibodies to cardiolipin (aCL), β2-glucoprotein-1(aβ2-GP1), annexin V (aAnV) and prothrombin (aPT)) were determined with ELISA. Intima-media thickness (IMT) of the carotid artery wall and the presence of atherosclerotic plaques were revealed ultrasonographically according to the described ESH/ESC Guidelines. Results: The levels of hs-CRP, IL-6, TNF-α were significantly higher in ARD patients than in the control group, which indicates the disease activity. Furthermore, the patients with SLE had a significant correlation between IL-6 and SLEDAI-2K (r=0,471, p=0,002), 499, p=0, 001) , whereas the patients with RA had only significant correlation between hs- CRP and DAS28 (r=0, 355, p=0, 031) . The concentration of IgG aCL, IgG and IgM aβ2-GP1, IgM aAnV, IgG aPT, LA were higher in patients with SLE than in the control group, and the levels of IgG and IgM aCL, IgM aβ2-GP1, IgG and IgM aAnV, LA were higher in patients with RA v.s. the control group.
